Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Serina Therapeutics (SER) Tax Provisions (2019)

Serina Therapeutics' Tax Provisions history spans 1 years, with the latest figure at $18000.0 for Q4 2019.

  • For Q4 2019, Tax Provisions changed N/A year-over-year to $18000.0; the TTM value through Dec 2019 reached $148000.0, changed N/A, while the annual FY2020 figure was -$150000.0, 201.35% down from the prior year.
  • Tax Provisions for Q4 2019 was $18000.0 at Serina Therapeutics, down from $54000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $73000.0 in Q1 2019 and bottomed at $3000.0 in Q2 2019.